22-24302290-C-T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 1P and 14B. PP2BP4_StrongBP6_ModerateBS1BS2
The NM_015330.6(SPECC1L):c.59C>T(p.Thr20Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000768 in 1,613,920 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Synonymous variant affecting the same amino acid position (i.e. T20T) has been classified as Likely benign.
Frequency
Consequence
NM_015330.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SPECC1L | NM_015330.6 | c.59C>T | p.Thr20Met | missense_variant | 3/17 | ENST00000314328.14 | |
SPECC1L-ADORA2A | NR_103546.1 | n.367C>T | non_coding_transcript_exon_variant | 3/20 | |||
SPECC1L | NM_001145468.4 | c.59C>T | p.Thr20Met | missense_variant | 2/16 | ||
SPECC1L | NM_001254732.3 | c.59C>T | p.Thr20Met | missense_variant | 2/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SPECC1L | ENST00000314328.14 | c.59C>T | p.Thr20Met | missense_variant | 3/17 | 1 | NM_015330.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152052Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000147 AC: 37AN: 251424Hom.: 1 AF XY: 0.000213 AC XY: 29AN XY: 135882
GnomAD4 exome AF: 0.0000759 AC: 111AN: 1461868Hom.: 1 Cov.: 31 AF XY: 0.000113 AC XY: 82AN XY: 727240
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152052Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74248
ClinVar
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 07, 2021 | - - |
SPECC1L-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 26, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at